A Debate on the Pros and Cons of 23-g vs. 25-g Vitrectomy

AMD Treatment Trends Call Attention to Cost/Benefit Considerations

As AMD treatment choices grow, can comparison-shopping be far behind?

By Rochelle Nataloni, contributing writer

Childhood Rubeosis Iridis and Retinal Ischemia Secondary to Hereditary Thrombophilia

Clinical Trials Update

Coding Q&A

Employing Occupational Therapists to Assist the Low-Vision Population

A viable option in assisting low-vision patients

By MARY WARREN, MS, OTR

Face Off

By ABDHISH R. BHAVSAR, MD

Macugen Widely Being Adopted by Retina Specialists

Survey also shows high interest in Avastin and Lucentis.

By Jerry Helzner, contributing editor

New Products & Services

Point/Counterpoint

Two physicians comment on their use of Lucentis and Macugen.

Subspecialty News

Technology Update: NIDEKMP-1 MicroPerimeter

Tracking fixation function places device in a category all its own

Upfront

Where do Lutein and Zeaxanthin Fit?

A leading researcher discusses their roles in the AMD treatment and prevention equation.